NovaBridge Biosciences (NBP) Change in Acquisitions & Divestments (2019 - 2024)

NovaBridge Biosciences (NBP) posted quarterly Change in Acquisitions & Divestments of -$81.4 million for Q4 2024, down 40.92% on a QoQ basis from -$57.8 million in Q3 2024.

NovaBridge Biosciences (NBP) Change in Acquisitions & Divestments (2019 - 2024) Analysis & Trends

NovaBridge Biosciences (NBP) has reported Change in Acquisitions & Divestments for 3 consecutive years, with -$81.4 million the latest figure, recorded in Q4 2024.

  • Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to -$81.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$139.2 million (down 164.44% YoY) and the FY2025 annual result came in at -$50.0 million, up 74.35% from the prior year.
  • Change in Acquisitions & Divestments eased to -$81.4 million in Q4 2024 per NBP's latest filing, from -$57.8 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for NBP reached as high as $336.0 million in Q4 2020 and fell as low as -$81.4 million in Q4 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 NovaBridge Biosciences 397.57 Mn 397.57 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -81.43 Mn
Dec 31, 2024 -81.43 Mn
Sep 30, 2024 -57.79 Mn
Sep 30, 2024 -57.79 Mn
Dec 31, 2020 336.02 Mn
Dec 31, 2020 336.02 Mn
Sep 30, 2020 19.27 Mn
Sep 30, 2020 19.27 Mn
Dec 31, 2019 31.31 Mn
Dec 31, 2019 31.31 Mn